 five-day bismuth-fre tripl therapi erad helicobact pylori reduct duoden ulcer relaps previou studi erad helicobact pylori signific reduct rate duoden ulcer DU relaps aim studi long-term effect bismuth-fre tripl therapi erad pylori reduct DU relaps inform consent patient DU infect breath test BT studi patient combin furazolidon amoxicillin metronidazol time day day addit eventu classic antiulc agent attend physician BT interv day pylori erad endoscopi BT month therapi possibl recurr forty-eight patient trial patient neg pylori month end treatment posit ninety-two percent patient bacteria ulcer asymptomat symptomat occasion pain therapi patient posit activ ulcer patient symptomat antiulc drug month treatment combin treatment furazolidon amoxicillin metronidazol day well-toler inexpens effect therapeut regim erad pylori abolit DU relaps patient follow-up period month